Zyprexa appeal rejected by Supreme Court
The U.S. Supreme Court has refused to revive a bid to press a $6.8 billion class-action suit against Eli Lilly and Co. over the marketing of Zyprexa, the company’s schizophrenia treatment.
Health Care
Articles
Lilly, partner find no Bydureon effect on heart rhythm
Eli Lilly and Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. said an analysis of a 148-patient trial found no evidence that their experimental Bydureon diabetes drug causes prolonged heart rhythms.
Planned Parenthood defunding blocked
Planned Parenthood of Indiana expects to resume offering services to Medicaid patients following a judge's ruling that the state is not allowed to cut off the organization's public funding for general health services solely because it also provides abortions.
Lilly diabetes pill recommended for EU approval
Eli Lilly and Co. and Boehringer Ingelheim GmbH’s Trajenta medicine for Type 2 diabetes has been recommended for approval in Europe, putting the drug on track to enter the region’s market this year.
WellPoint goes online to educate about ER use
Health insurer WellPoint Inc. has enlisted Google Maps for new websites that help patients think twice before they visit an emergency room for care that a less-expensive retail health clinic could handle.
Groups call for probe of St. Francis hospital over charity care
Citizens Action Coalition Education Fund and Indiana Legal Services Inc. claim that “a good number” of Indianapolis south-side residents who should have qualified for reduced or waived bills at St. Francis were instead steered into payments plans.
EU approves Lilly’s weekly diabetes drug Bydureon
European Union regulators have approved the first once-per-week diabetes medication, the companies that developed the drug said Tuesday.
Planned Parenthood stops seeing Medicaid patients
Planned Parenthood of Indiana is no longer seeing Medicaid patients because a federal judge hasn't ruled yet on its attempt to block a new Indiana law cutting funding for certain abortion providers, officials said Monday.
Survey: Hospitals still rewarding docs for volume
The latest physician recruitment survey from Texas-based Merritt Hawkins shows three-quarters of all physician searches include a performance bonus for the doctor. Fewer than 10 percent of those bonuses are tied to something other than volume of procedures.
Troubled economy fueling hospital deals
Battered by stagnant population growth and blue-collar job loss, Howard Regional Health is merging with Indiana University Health—a deal that reflects the challenges faced by hospitals in Indiana’s outlying cities.
IU Health strikes deal with Central Indiana Cancer Centers
Central Indiana Cancer Centers sold its five facilities to IU Health and transferred its 150 employees to the Indianapolis-based hospital system. The 16 physicians in the practice will remain independent, but they have signed a service agreement with IU Health that pulls the two entities into a tight embrace.
Carmel senior-living project to create 340 jobs
Carmel Mayor Jim Brainard on Tuesday unveiled details of a multimillion-dollar project expected to create more than 200 construction jobs and 140 permanent positions over the next two years.
WellPoint pays big to tap fast-growing Medicare market
Analysts raised their eyebrows at the $800 million reportedly paid by WellPoint Inc. to acquire a West Coast Medicare plan, but with the commercial health insurance business stagnating, Medicare is vital to WellPoint’s future growth.
Positron plans $55 million cyclotron project, 80 jobs
Medical imaging equipment maker Positron Corp. has agreed to move its operations to Noblesville, where it plans to invest $55 million to open a high-tech facility that will make isotopes used in cardiac PET scans.
Roche to add 50 HR employees in Indianapolis
Swiss health care giant Roche Holding AG has selected its diagnostics division in Indianapolis as the site for a new North America human resources center, a move that will add 50 employees to its local operations.
Lilly enters collaboration deal with Swiss company
Drugmaker Eli Lilly and Co. has signed a deal with Swiss company Synthes Inc. to co-promote the bone drug Forteo and develop other potential orthopedic treatments.
Riley’s No. 2 executive follows boss out the door
Brett D. Lee, the chief operating officer at Riley Hospital for Children, announced plans Wednesday to leave the hospital for a new job in Atlanta, just three weeks after Riley CEO Dan Fink resigned.
Lilly wins ruling in dispute with Amylin over diabetes drugs
Eli Lilly and Co. won a ruling in a lawsuit brought by Amylin Pharmaceuticals Inc., which wants to prevent Lilly from using the same people to sell Amylin’s diabetes drug and that of a competitor.
WellPoint paying almost $800M for CareMore
Indianapolis-based WellPoint Inc. agreed to acquire CareMore Health Group to expand Medicare coverage in California, Arizona and Nevada. The insurer paid almost $800 million, according to people familiar with the deal.
Drug industry outlook negative through 2012, Moody’s says
Earnings growth will continue to slow in 2011 for most of the industry’s biggest companies, analyst predicts.